Life Science Company
Kite Pharma has acquired 2 companies of its own, including 1 in the last 5 years.
Kite Pharma’s largest acquisition to date was in 2017, when it acquired Cell Design Labs for $567M. Kite Pharma has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Kite Pharma’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 2